Thomas J. Klima - 01 Sep 2022 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
Chief Commercial & Operating Officer
Signature
/s/ Helen C. Fu, Attorney-in-Fact
Issuer symbol
BLUE
Transactions as of
01 Sep 2022
Net transactions value
$0
Form type
4
Filing time
06 Sep 2022, 17:26:30 UTC
Previous filing
07 Jun 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLUE Common Stock Award $0 +11,000 +15% $0.000000 82,439 01 Sep 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLUE Stock Option (right to buy) Award $0 +22,000 $0.000000 22,000 01 Sep 2022 Common Stock 22,000 $6.55 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit awards vest over a four-year period at the rate of 25% on 09/01/2023, 25% on 09/01/2024, 25% on 09/01/2025, and 25% on 09/01/2026.
F2 This stock option vests over a four-year period at the rate of 25% on 09/01/2023 and then in 36 equal monthly installments thereafter

Remarks:

Chief Commercial & Operating Officer